Skip to Main

Search

Results 451 to 460 of 938 for ""

The α7 protein is ready for its close-up: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/the-a7-protein-is-ready-for-its-close-up.html

UT Southwestern researchers have identified the structure of a key member of a family of proteins called nicotinic acetylcholine receptors in three different shapes.

New CAR T-cell therapy extends remission in heavily relapsed multiple myeloma patients: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/new-car-t-cell-therapy.html

A new type of CAR T-cell therapy more than triples the expected length of remission for multiple myeloma patients who have relapsed several times, according to an international clinical trial with UT Southwestern as the lead enrolling site.

UTSW findings advance RAS inhibitors for use in fighting more cancers: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/ras-inhibitors-for-use-in-fighting-more-cancers.html

New findings by UT Southwestern researchers help better understand the how one of the most commonly mutated genetic drivers of cancer passes signals that cause the disease.

Scientists identify cells responsible for liver tissue maintenance and regeneration: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/scientists-identify-cells-responsible-for-liver-tissue.html

While the amazing regenerative power of the liver has been known since ancient times, the cells responsible for maintaining and replenishing the liver have remained a mystery.

UTSW is a founding member of new sickle cell clinical trials network: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/new-sickle-cell-clinical-trials-network.html

In a move that will increase access and efficiency of clinical trials for patients with sickle cell disease.

Tumors hijack the cell death pathway to live: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/tumors-hijack-the-cell-death-pathway-to-live.html

Cancer cells avoid an immune system attack after radiation by commandeering a cell signaling pathway that helps dying cells avoid triggering an immune response

Speeding treatment for urinary tract infections in children: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/speeding-treatment-for-urinary-tract-infections-in-children.html

A study led by UT Southwestern and Children’s Health researchers defines parameters for the number of white blood cells that must be present in children’s urine at different concentrations to suggest a urinary tract infection (UTI).

Study details how general anesthetics and 'benzos' act on receptors in the brain: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/how-general-anesthetics-and-benzos-act-on-receptors.html

As you drift into unconsciousness before a surgery, general anesthetic drugs flowing through your blood are putting you to sleep by binding mainly to a protein in the brain called the ɣ-aminobutyric acid type A (GABAA) receptor.

UT Southwestern joins partner network of National Academies’ Action Collaborative on preventing sexual harassment in higher education : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/preventing-sexual-harassment-in-higher-education.html

UT Southwestern Medical Center is one of 13 inaugural organizations joining a newly launched partner network of The National Academies’ Action Collaborative on Preventing Sexual Harassment in Higher Education to support evidence-based policies and practices for preventing sexual harassment.

Clinical trial shows stereotactic radiation extends systemic therapy and slows kidney cancer progression : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/stereotactic-radiation-extends-systemic-therapy.html

A new study by the Kidney Cancer Program (KCP) at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center shows that highly focused radiation to isolated metastases that progress despite drug therapy can prolong drug use in kidney cancer patients, saving the few other drugs for treating

Back-to top